Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Recruiting 3Withdrawn 1Unknown 1

Sponsor Class

OTHER 2INDUSTRY 2NIH 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gynecologic 5Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 8Neoplasms 7Uterine Cervical Neoplasms 5Head and Neck Neoplasms 5Prostatic Neoplasms 4Melanoma 4Glioblastoma 4Squamous Cell Carcinoma of Head and Neck 3Sarcoma 3Hematologic Neoplasms 3Glioma 3Brain Neoplasms 3Uterine Cervical Dysplasia 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Neuroblastoma 2Lymphedema 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hematopoietic and Lymphatic System Neoplasm 2Carcinoma, Squamous Cell 2Atypical Squamous Cells of the Cervix 2Astrocytoma 2Xeroderma Pigmentosum 1Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Trichothiodystrophy Syndromes 1Tongue Neoplasms 1Testicular Neoplasms 1Teratoma 1

Interventions

Cisplatin 182Radiotherapy 81Paclitaxel 80Brachytherapy 74Carboplatin 72pembrolizumab 63Bevacizumab 40Surveys and Questionnaires 29Colposcopy 29Radiation 28Gemcitabine 28Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 27Topotecan 26Magnetic Resonance Spectroscopy 24Blood Specimen Collection 23human papillomavirus vaccine, L1 type 16, 18 22Nivolumab 22Drug Therapy 22Papillomavirus Vaccines 20atezolizumab 19Platinum 19Radiotherapy, Intensity-Modulated 18Biopsy 18Docetaxel 17Taxes 16Cyclophosphamide 16Early Intervention, Educational 151,2-diaminocyclohexaneplatinum II citrate 15Methods 14fludarabine 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Restraint, Physical × Clear all
NCT07276360 2026-03-27

HypoRTCx-UG

Uganda Cancer Institute

Phase 2 Recruiting
278 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT07480902 2026-03-18

Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer

Timser SAPI de CV

Phase NA Recruiting
558 enrolled
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Atypical Squamous Cells of the Cervix

NCT04857528 2026-03-04

Detecting HPV DNA in Anal and Cervical Cancers

University of Chicago

Recruiting
20 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms

NCT07211204 2026-03-03

Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population

Timser SAPI de CV

Phase NA Withdrawn
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Atypical Squamous Cells of the Cervix

NCT00632047 2013-08-26

Early Detection of Breast Cancer and Cervical Cancer in Women in India

National Cancer Institute (NCI)

Phase 2 Unknown
151,538 enrolled
BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡